UPC – Amgen v. Sanofi / Preliminary Objection rejected

In the case of Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH, the Court concluded that when the revocation action was filed, there was no infringement action relating to the same patent.

Therefore, the Central Division (Section Munich) has jurisdiction over the revocation action. 
The defendant's request to reject the revocation action and claim costs was rejected. 

The Court has granted leave to appeal due to the important legal questions raised in the case.


Posta un commento